We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Assetz Capital is a leading property-secured business marketplace lender in the UK and Europe. It provides loans to small and medium enterprises (SMEs), and property developers in the UK, financed by retail investors, institutional investors, government bodies and banks. The company has arranged loans of over £1 billion since its founding in April 2013. It ranked 53rd out of the UK’s top 100 fastest-growing technology companies for two consecutive years in the Sunday Times Tech Track 100, and funded the equivalent of 1 in 100 UK homes in the last two years. Assetz Capital aims to utilise the investment to fund legal and structuring work around the Coronavirus Business Interruption Loan Schemes (CBILS), have working capital for business development, grow its team, and possibly launch an Initial Public Offering (IPO) in the future.
days to go: Expired investment: £760,600
Award-winning non-dairy luxury ice cream, which is also organic and vegan. Coconuts Naturally will be launching their range of 5 flavours in over 600 supermarkets across the UK from March 2019. after successfully achieving listings with Ocado, Morrison’s and Asda. The company differentiates itself from competitors by primarily using coconut cream and unrefined coconut sugar in their products. Coconuts Naturally have won seven Great Taste Awards and Peter Jones of Dragon's Den has claimed it the best free-from ice cream he has tasted. The business is raising funds to increase brand awareness by entering international markets. Coconuts Naturally is stocked at 2 supermarkets in Dubai, as well as launching in Hong Kong soon and currently seeking product registration in Saudi Arabia. The company will be focusing on marketing campaigns via digital and in-store promotions. In addition, due to the upcoming supermarket launch, the business will also be increasing stock levels to meet consumer demand.
days to go: Expired investment: £422,580
Offering a more affordable fitness class solution through training small groups and providing unparalleled client care with 1-on-1 personal training sessions. Outrivals has grown rapidly since launching 3 years ago near the famous Old Street Roundabout and are raising funds to open 2 new sites, with plans to have a portfolio of 15 branches over the next 5 years. The company has a high retention rate, with a client life cycle averaging one year.
days to go: Expired investment: £88,450
A themed cocktail bar owner, craft beer brewer and gin brand creator that serves thousands of customers on a weekly basis. Liquid Art Group currently have 3 locations within affluent areas of Manchester and are now raising funds to open 12 more sites across the UK over the next 3 years. The company has become highly profitable and are ready to duplicate their proven business model after successfully running in a niche area of their market. More sites will result in reduced costs due to purchasing bulk goods from existing suppliers in greater quantities. This means that profit margins will increase, whilst more locations will provide additional streams of revenue. Liquid Art Group is also planning to develop and distribute their range of gin by creating new flavours and offerings.
days to go: Expired investment: £129,080
To help reduce wasted food, Daily Dose source 'wonky' fruit and veg for their organic cold-pressed juices. They sell over 40,000 drinks on average every month and supply their products to more than 150 stockists, as well as launching a café in 2017. They are currently researching methods to extend the shelf life of their juices. Daily Dose moved from a 500sq ft. to a 2500sq ft. facility in 2016, now they are raising funds to triple the size of their site.
days to go: Expired investment: £305,740
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph